Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0149514 (bronchitis)
 6,902 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The agar gel precipitin (AGP) and haemagglutination inhibition (HI) responses to vaccination with infectious bronchitis virus (IBV) were investigated in three flocks. The vaccines were administered by coarse spray in one large flock of commercial layers and via the drinking water in two smaller flocks of broiler breeders. In two flocks, one vaccinated by coarse spray and one vaccinated via the drinking water, the chicks had high levels of maternal antibody and failed to respond serologically to the primary vaccination at 2 to 3 weeks of age. However, a vigorous antibody response, probably due to cycling vaccine virus, was demonstrated at 6 to 7 weeks of age after the maternal antibodies had waned. By contrast the chicks in the third flock, with low levels of maternal antibody at 2 weeks, responded promptly and vigorously to the primary vaccination. Passive immunity, mediated by maternal antibodies, was thought to have inhibited the initial AGP and HI responses to vaccine in the first two flocks. Between 10 and 20 weeks, in spite of repeated vaccination, the IBV geometric mean HI titres did not increase and the number of AGP-positive sera remained low. In the densely populated group receiving the coarse spray, the AGP response was virtually absent and in those smaller groups of birds receiving water-borne vaccine only 33% became AGP-positive. As in the young chicks with passive immunity, active immunity in the older birds, associated either with deliberate vaccination or inadvertent cycling vaccine virus, was thought to have inhibited the serological responses to the second and third exposures to vaccine. There was a marked rise in the number of AGP-positive birds (84% and 68% respectively) at 25 weeks of age in two flocks. HI test results indicated that this was due to exposure to a field strain of IBV in one flock and to a cycling vaccine strain in the other. The AGP results at this time were similar in both of these flocks and this test could not be used to differentiate the responses to the different types of IBV. Only 25% of the sera were AGP-positive at 25 and 30 weeks in the third flock and therefore in such a flock any sudden rise to above 50% in the number of AGP-positive birds might be attributed to recent exposure to field or vaccine strains of IBV.
 ...
PMID:Field observations on serological responses to vaccine strains of infectious bronchitis virus administered by coarse spray and via the drinking water. 1877 Feb 19

Observations on the survival of infectious bronchitis virus in 3 mains waters showed that it survived for a much shorter period in one of them which contained a relatively high content of copper (0.2 mg/1). Other factors adversely affecting survival were 5 ppm of free residual chlorine and increase in temperature over the range of 20-35 degrees C. Survival of virus was prolonged in the presence of 0.1% w/v powdered skim milk (PSM), 1,0% w/v poultry mash, 1,0% w/v fresh poultry droppings, rust and 0,01% sodium thiosulphate. In part this protection might have been against the high copper content of the water used but 0.1 % PSM protected also against the combined effect of a temperature of 35 degrees C and 5 pmm chlorine. Factors which seemed to exert relatively little effect on virus survival were the nature of the container, whether of polystyrene, galvanized iron or glass, the pH range of 7-9 and total hardness of the water.
 ...
PMID:The survival of infectious bronchitis (IB) virus in water. 1877 88

Senecio cannabifolius var integrilifolius (Compositae), locally known as "Fanhuncao" in China, is a folk herb used for the treatment of pneumonia, virus influenza and bronchitis. To investigate the chemical constituents of this herb, water extract of the aerial parts was subjected to various chromatography on normal/reversed phase silica gel and Sephadex LH-20 column. Eleven compounds were obtained and identified on the basis of their physicochemical properties and spectroscopic analysis as senecine (1), p-hydroxy-benzeneacetic acid (2), protocatechuic acid (3), 2,5-dihydroxy-benzeneacetic acid (4), 3,4-dihydroxy-benzeneacetic acid (5), vanillic acid (6), caffic acid (7), succinic acid (8), 2-furoic acid (9), 1, 2, 4, 5-tetrahydro-jacaranone (10), and 4-(pyrrolidin-2-one)-phenylacetic acid (11). Compound 1 was structurally identified to be a new compound; the other compounds were isolated from this plant for the first time.
 ...
PMID:A new compound from Senecio cannabifolius var integrilifolius. 1882 66

Subunit vaccines containing haemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus (NDV), formulated as water-in-oil-in-water (W/O/W) emulsions, were prepared. First, the suitable constituents of a W/O/W emulsion adjuvant were investigated with polyvalent vaccines using NDV, infectious bronchitis virus and Haemophilus paragallinarum. The W/O/W emulsion adjuvant, composed of the antigen in phosphate-buffered saline (PBS), liquid paraffin, squalene, diglyceryl monooleate, polysorbate 80 and PBS in a 30:25:10:5:2:28 ratio, induced a good antibody response with less adverse local reactions. HN protein of NDV was expressed by an improved baculovirus expression vector, a hybrid nucleopolyhedrovirus (HyNPV) between Autographa californica NPV and Bombyx mori NPV,and was prepared from silkworm pupae infected with the recombinant baculovirus, HyNPV-HN. Then, the W/O/W emulsion vaccine containing HN protein was prepared using the aforementioned constituents. Chickens showed 100, 100 and 80% protection against challenge exposure to virulent NDV at 4 weeks after vaccination with W/O/W emulsion vaccines containing 30, 6 and 3% of HyHPV-HN-infected pupae, respectively. The vaccines containing HN protein did not induce adverse local reactions at the site of injection. The subunit vaccine for NDV containing HN protein expressed in the recombinant baculovirus-infected pupae, formulated as a W/O/W emulsion vaccine composed of the antigen in PBS, liquid paraffin, squalene, diglyceryl monooleate, polysorbate 80 and PBS in a 30:25:10:5:2:28 ratio, was therefore found to be safe and effective.
 ...
PMID:Safety and efficacy of water-in-oil-in-water emulsion vaccines containing Newcastle disease virus haemagglutinin-neuraminidase glycoprotein. 1918 40

Parachlamydia acanthamoebae is a Chlamydia-like organism that easily grows within Acanthamoeba spp. Thus, it probably uses these widespread free-living amoebae as a replicative niche, a cosmopolite aquatic reservoir and a vector. A potential role of P. acanthamoebae as an agent of lower respiratory tract infection was initially suggested by its isolation within an Acanthamoeba sp. recovered from the water of a humidifier during the investigation of an outbreak of fever. Additional serological and molecular-based investigations further supported its pathogenic role, mainly in bronchiolitis, bronchitis, aspiration pneumonia and community-acquired pneumonia. P. acanthamoebae was shown to survive and replicate within human macrophages, lung fibroblasts and pneumocytes. Moreover, this strict intracellular bacterium also causes severe pneumonia in experimentally infected mice, thus fulfilling the third and fourth Koch criteria for a pathogenic role. Consequently, new tools have been developed for the diagnosis of parachlamydial infections. It will be important to routinely search for this emerging agent of pneumonia, as P. acanthamoebae is apparently resistant to quinolones, which are antibiotics often used for the empirical treatment of atypical pneumonia. Other Chlamydia-related bacteria, including Protochlamydia naegleriophila, Simkania negevensis and Waddlia chondrophila, might also cause lung infections. Moreover, several additional novel chlamydiae, e.g. Criblamydia sequanensis and Rhabdochlamydia crassificans, have been discovered and are now being investigated for their human pathogenicity.
 ...
PMID:Parachlamydia acanthamoebae, an emerging agent of pneumonia. 1922 Mar 36

To determine the coverage of infectious bronchitis virus (IBV) vaccine field boost in commercial broilers, estimate the relative amount of vaccine virus in the trachea, and follow the clearance of the vaccine, we collected approximately 100 tracheal swabs at various times postvaccination from 10 different flocks and used real-time reverse transcriptase-PCR (RT-PCR) to detect the virus. This allowed us to detect vaccine virus in as few as 3% of the birds in a flock of 20,000 birds with a 95% confidence level. We found that the number of birds positive for IBV vaccine following vaccination in the field resembled a parabolic-shaped curve that peaked around 14 days postvaccination, or it resembled a sinusoidal-type wave with a frequency of about 2 wk. The patterns did not appear to correlate with water or spray vaccination methods, nor did they correlate with the type of backpack sprayer used. The highest number of positive birds in a flock ranged from 66% to 100%. The viral genome copies in the tracheal swabs, as determined by real-time RT-PCR, ranged from 1 x 10(2.6)/ml to 1 x 10(5.2)/ml and, in most studies, had a positive correlation with the number of birds positive for vaccine virus in the flock. On the last sample day of each study, 21, 28, or 35 days postvaccination, from 12% to 66% of the birds were still positive for vaccine virus, and although different IBV vaccine types were used in each study, only Arkansas vaccine virus was identified in selected samples on those days. Arkansas vaccine virus was also the only virus identified in selected samples at 1, 3, and 5 days postvaccination, clearly indicating that Arkansas vaccine virus is persisting in the birds. Protection studies conducted on birds vaccinated with Arkansas- and Delaware-type vaccines and removed from the field at 21 days postvaccination showed complete protection against challenge with Delaware (except for one bird), whereas protection against Arkansas challenge was between 37.5% and 62.5%. Our findings show that introduction of IBV vaccines into a commercial broiler flock do not necessarily follow a seemingly logical pattern of a high number of birds infected followed by clearance from the trachea, but resembled either a parabolic curve or a sinusoidal-type wave. In addition, Arkansas vaccine viruses are clearly persisting in commercial broilers, which may be because of incomplete protection observed for that IBV type.
 ...
PMID:Infectious bronchitis virus field vaccination coverage and persistence of Arkansas-type viruses in commercial broilers. 1963 Feb 21

Byrsonima verbascifolia, popularly known in Brazil as murici, is a medicinal plant widely used in the treatment of bacterial and viral infections, Chagas's disease, diarrhea, bronchitis, cough and fever, as well as for protection of the intestinal mucosa. Since chemotherapy and radiotherapy, broadly employed in the treatment of cancer, can have undesirable side effects, such as inducing DNA damage in normal cells, it would be useful to investigate compounds that inhibit or reduce these effects. A lyophilized water extract of murici, used at three different concentrations (25, 50, and 100 mg/mL), was tested to determine if it could reduce damage induced by the antineoplastic compound doxorubicin in somatic cells of Drosophila melanogaster, analyzed by SMART/wing. The frequency of mutant spots in descendants from standard and high bioactivation crosses was significantly reduced by treatment with murici extract. Further studies are needed using other experimental models, to determine if murici has the potential to be employed by cancer patients receiving chemotherapy.
 ...
PMID:Modulatory effect of Byrsonima verbascifolia (Malpighiaceae) against damage induced by doxorubicin in somatic cells of Drosophila melanogaster. 2009 36

Infectious bronchitis virus (IBV) is, in spite of vaccination, still a major cause of respiratory problems in broilers and of poor egg production in breeders and layers in many parts of the world. A possible cause of the insufficient protection induced by vaccination is an inadequate application of the vaccine. This paper reports the results of two field studies. In the first, the results of the alpha-IBV IgM enzyme-linked immunosorbent assay (ELISA) on post-vaccination sera were compared with the efficacy of the IBV vaccination against homologous challenge of the same broilers. The results showed that groups with at least 50% positive sera in the IgM ELISA at 10 days post vaccination had a high level of protection against challenge. Most groups of broilers with a low level of IgM ELISA positives had a low or moderate level of protection against challenge. In a second field study, the IgM response to IBV vaccination was compared with detailed information of the vaccination process of 360 spray-vaccinated flocks of about 2-week-old broilers, layer pullets, broiler breeders and broiler grandparents. The information included parameters such as flock size, type of chicken, housing, age of the chicken, application route, vaccine, dose, water quantity and temperature, ventilation and light management, combination with other vaccines and temperature of the house. The aim was to identify factors that might be associated positively or negatively with the IgM response and thereby with the expected level of protection against homologous challenge under field conditions. Significant associations were detected between the level of IgM response and factors regarding type of bird, flock size, housing type, ventilation management, light management, age/interval of vaccination, interval between vaccination and blood sampling, and temperature of the water that was used to reconstitute the vaccine. This knowledge can be useful to improve the average efficacy of IBV vaccination in the field.
 ...
PMID:Efficacy of infectious bronchitis virus vaccinations in the field: association between the alpha-IBV IgM response, protection and vaccine application parameters. 2039 May 47

In the present study we describe the rapid development of an attenuated live vaccine for GA08, a new serotype of infectious bronchitis virus, using a heat-treatment method. Incubation of the GA08 strain of IBV at 56 degrees C and passage in embryonated eggs was used as a method to fast track the attenuation process. The virus was incubated in a 56 degrees C water bath and aliquots were removed every 5 min for up to 1 h, and then each aliquot was inoculated into 10-day-old embryonated eggs. Virus with the longest incubation time that produced lesions in the embryos was harvested, again incubated at 56 degrees C as described and passaged in embryonated eggs. Attenuation of the virus, designated GA08/GA08HSp16/08, was verified in 1-day-old specific pathogen free chicks. A 10x dose of the vaccine was found to be safe for 2-week-old broiler chicks of commercial origin. The efficacy of the heat-treated attenuated virus was determined by vaccinating broiler chicks of commercial origin at 1 and 14 days of age intraocularly/intranasally. Vaccinated birds that were challenged with 10(4.5) median embryo infectious doses of pathogenic GA08 virus/bird at 28 days of age were protected from the disease, and challenge virus was only detected in the trachea of one of 21 birds by real-time reverse transcriptase-polymerase chain reaction at 5 days post challenge. The attenuation process took 10 weeks to complete, which is a substantially shorter time than required to attenuate infectious bronchitis virus by serial passage in embryonated eggs without heat treatment (38 weeks or more).
 ...
PMID:Rapid heat-treatment attenuation of infectious bronchitis virus. 2054 30

Eggshell abnormalities were seen in the apex of eggs in two of three flocks of multi-age, Hy-Line layer chickens housed on a farm in Northern Italy. Approximately 1.3% to 1.8% of eggs in one flock were affected, amounting to 300-400 eggs per day; the abnormalities resulted in a great deal of breakage and spoilage of healthy eggs. The mean weight of eggs was also reduced. Egg abnormalities in a second flock were less severe. Mycoplasma synoviae was detected in birds from both of the affected flocks by serologic, cultural, and molecular techniques, but not in a third, adjacent flock where no eggshell abnormalities were seen. Treatment with tylosin, administered in the drinking water for 5 days, resulted in an immediate improvement of eggshell quality and egg weight. There was no evidence of infectious bronchitis virus in the flocks.
 ...
PMID:Treatment of eggshell abnormalities and reduced egg production caused by Mycoplasma synoviae infection. 2060 49


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>